Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride - Kohler, Sven; Kaspers, Stefan; Salsali, Afshin; Zeller, Cordula; Woerle, Hans J. (Diabetes care, 2018)
Keywords: Adult; Aged; Antidiabetics; Benzhydryl Compounds - adverse effects; Benzhydryl Compounds - therapeutic use; Bone density; Bone Density - drug effects; Bone mineral density; Clinical trials; Clinical Trials, Phase I as Topic - statistics & numerical data; Clinical Trials, Phase II as Topic - statistics & numerical data; Clinical Trials, Phase III as Topic - statistics & numerical data; Data analysis; Data processing; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Female; Fractures; Fractures, Bone - chemically induced; Fractures, Bone - epidemiology; Glucosides - adverse effects; Glucosides - therapeutic use; Humans; Hypoglycemic Agents - therapeutic use; Male; Medical research; Metformin; Metformin - therapeutic use; Middle Aged; Patients; Placebo effect; Placebos; Randomized Controlled Trials as Topic - statistics & numerical data; Research design; Sulfonylurea Compounds - adverse effects; Sulfonylurea Compounds - therapeutic use